F055 Pediatric Dermatology for the Adult Dermatologist
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Many skin disorders are more commonly diagnosed in children; others have a unique presentation in the pediatric population. This session will help participants identify and treat skin conditions in children, with a specific focus on how this care differs from adults. The session will provide guidance to general dermatologists on a child-centric approach to several disorders. Emphasis will be placed on understanding the unique differential diagnosis for skin conditions and the challenges of treatment in this age group.
LEARNING OBJECTIVES
Identify key differences in the presentation of skin disorders in children when compared to adults.
Appropriately manage pediatric patients with skin disease, with special emphasis on our knowledge of natural history/outcomes, and optimal treatment strategies in children.
Develop a treatment strategy for pediatric patients with skin diseases, recognizing similarities and differences from adult patients.
SCHEDULE
9:00 PM
Big Tools for Little Kids With Atopic Dermatitis
Stephen Raymond Humphrey, MD, FAAD
9:20 PM
Babies, Beta-Blockers, Birthmarks, and Beams: Hemangioma Management and Laser Pearls
Ross Brockman, DO, FAAD
9:40 PM
Little Kids; Big rashes. Cases of ACD in Children.
JiaDe Yu, MD, FAAD
10:00 PM
Foreign Invaders: Pearls and Pitfalls
Jennifer Ruth, MD, FAAD
10:20 PM
Young Patients, Old Challenges: Pro Tips for Hidradenitis Suppurativa and Peds Derm Procedures
Colleen Cotton, MD, FAAD
10:40 PM
Panel Discussion
SPEAKERS
Ross Brockman, DO, FAAD
Colleen Cotton, MD, FAAD
Stephen Raymond Humphrey, MD, FAAD
Jennifer Ruth, MD, FAAD
JiaDe Yu, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Ross Brockman, DO, FAAD
Sanofi/Regeneron – Speaker(Honoraria); Solta Medical – Consultant (1099 relationship)(Honoraria);
Colleen Cotton, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Arcutis Biotherapeutics – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Salary); HS Foundation – Board of Directors(No Compensation Received), Investigator(Grants/Research Funding); Inner Archways LLC – Advisory Board(Other Financial Benefit); Janssen Biotech – Advisory Board(Other Financial Benefit); LEO Pharma, US – Advisory Board(Honoraria); Novartis – Other(Other Financial Benefit); Pierre Fabre – Consultant(Honoraria); Regeneron – Investigator(Salary); TARGET Pharma – Investigator(Salary); UCB – Other(Other Financial Benefit);
Stephen Raymond Humphrey, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding);
Jennifer Ruth, MD, FAAD
No financial relationships exist with ineligible companies.
JiaDe Yu, MD, FAAD
American Contact Dermatitis Society – Board of Directors(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Dermavant Sciences – Speaker/Faculty Education(Honoraria); Incyte – Advisory Board(Honoraria); National Eczema Association – Consultant(Fees), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria);